The Politicization of a Menthol Cigarette Ban in the United States: What the Medical and Public Health Workforce Can Do to Support Evidence-Based Policymaking.

Neptune E, Brown JL

Applying an updated brain injury guideline classification to interhospital transfer of patients with traumatic brain injury: Who benefits most?

Tenhoeve SA, Cole KL, Jhandi S, Findlay MC, Larkin E, Brown J, Orton CJ, Andra K, Cortez J, Grandhi R, Lombardo S, Nunez J, Enniss T, Koch R, Menacho ST

Paravalvular Leak After Transcatheter Aortic Valve Implantation: Results From 3600 Patients.

Warraich N, Brown JA, Ashwat E, Kliner D, Serna-Gallegos D, Toma C, West D, Makani A, Wang Y, Sultan I

Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential.

Kohutek ZA, Caslin HL, Fehrenbach DJ, Heimlich JB, Brown JD, Madhur MS, Ferrell PB, Doran AC

Development and validation of an MMPI-3 Antagonism scale.

Sellbom M, Brown JR

It's Not Too Late: Physical and Social Activity Slow Cognitive Decline in Those Living With Mild Cognitive Impairment.

Dhakal U, McLaughlin SJ, Kim S, Vivoda JM, Roberts AR, Brown JS

Predictors of receiving a doxycycline postexposure prophylaxis (Doxy-PEP) prescription for the prevention of bacterial sexually transmitted infections (STIs) in a community-based clinic: a case-control study.

Ogunbajo A, Henry C, Barney A, Anderson T, Brown J, Hickson D

Islet Autoantibody Screening Throughout Australia Using In-Home Blood Spot Sampling: 2-Year Outcomes of Type1Screen.

Wentworth JM, Sing ABE, Naselli G, Huang D, Azidis-Yates E, Mandlebe B, Brown JD, McGorm K, Hall C, Redl L, Kludas R, Haldar A, Healy F, Gilbert A, Watson K, Chiang C, Couper JJ, Huynh T, Davis EA, Craig ME, Cameron FJ, Kay TW, Harrison LC, Colman PG

Exploratory analysis of biological age measures in a remyelination clinical trial.

McMurran CE, de Meo E, Cunniffe NG, Brown JWL, Prados F, Kanber B, Cole JH, Coles AJ, Hägg S, Chard DT

Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era.

Fatola A, Evans MD, Brown J, Davis E, Johnson A, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Eubanks S, Akwaa F, Clover T, Kreuziger LB, Sadler JE, Sridharan M, Go RS, McCrae KR, Upreti HV, Lim MY, Kocher NK, Gangaraju R, Zheng XL, Raval JS, Masias C, Cataland SR, Mazepa M, Chaturvedi S